glp 1 for liver health Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective American drugmakers pushed GLP1 therapies

Semaglutide does not directly suppress thyroid hormone production, but it reduces overall caloric intake and may lower the metabolic rate slightly as weight decreases

Liraglutide suppresses TNF--induced degradation of extracellular matrix in human chondrocytes: A therapeutic implication in osteoarthritis

As a dual GIP/GLP-1 receptor agonist, tirzepatide has demonstrated superior weight loss outcomes in clinical trials compared to semaglutide alonea topic we explore in depth in our Tirzepatide vs

Frequently Asked Questions Is compounded semaglutide as effective as brand-name Ozempic

1,2 Initially developed as antidiabetic treatments, GLP-1 RAs and, more recently, dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have demonstrated favourable metabolic outcomes with significant and sustainable weight loss in large randomised controlled trials (RCTs) and real-world studies